RNA-sequencing dissects the transcriptome of polyploid cancer cells that are resistant to combined treatments of cisplatin with paclitaxel and docetaxel

RNA-sequencing was performed to identify differentially expressed genes (DEGs) that may contribute to drug resistance in cancer cells treated with combined treatments of cisplatin with paclitaxel and docetaxel.